Tag: Silence Therapeutics

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Silence Therapeutics

Antisense and RNAi Therapeutics Market Incredible Potential Examined in New Research Report

Added to Collection on: 2022-10-15 06:24:07

Tags for this article:

Nucleic acids
Branches of biology
RNA
Biology
Gene expression
Therapeutic gene modulation
Molecular biology
RNA interference
Antisense therapy
Silence Therapeutics
Arbutus Biopharma
Alnylam Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Sirnaomics to Present Latest Developments on GalAhead™ Therapeutic Platform at ... - BioSpace

Added to Collection on: 2022-10-19 19:50:36

Tags for this article:

RNA
Branches of biology
Biology
Gene expression
Biochemistry
RNA interference
Small interfering RNA
Samarsky
Silence Therapeutics
Dmitry Samarsky
Sirnaomics Ltd.
China

Click the tags to see associated articles and topics

View Article Details
Silence Therapeutics (NASDAQ:SLN) Trading 5.5% Higher - Defense World

Added to Collection on: 2023-12-31 13:44:10

Tags for this article:

Equity securities
Alternative investment management companies
Hedge funds
Financial regulation
Short
Dividend
Silence Therapeutics
NASDAQ
Schonfeld Strategic Advisors
Stock

Click the tags to see associated articles and topics

View Article Details
Focus on mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides - Yahoo Finance

Added to Collection on: 2024-01-31 19:06:59

Tags for this article:

RNA
Gene expression
Molecular biology
Molecular genetics
RNA therapeutics
RNA interference
Silence Therapeutics
Small interfering RNA
Arcturus Therapeutics
Messenger RNA
MRNA vaccine
COVID-19 vaccine

Click the tags to see associated articles and topics

View Article Details
RNA Therapeutics Market Research Report 2023: Focus on mRNA - GlobeNewswire

Added to Collection on: 2024-01-31 11:04:12

Tags for this article:

RNA
Gene expression
Molecular biology
Molecular genetics
RNA therapeutics
RNA interference
Silence Therapeutics
Small interfering RNA
Arcturus Therapeutics
Messenger RNA
MRNA vaccine
Novartis

Click the tags to see associated articles and topics

View Article Details
Zerlasiran by Silence Therapeutics for Atherosclerosis: Likelihood of Approval

Added to Collection on: 2024-02-19 17:59:55

Tags for this article:

RNA
Molecular genetics
Molecular biology
Gene expression
RNA interference
Novartis
Silence Therapeutics
Small interfering RNA
Pharmaceutical industry

Click the tags to see associated articles and topics

View Article Details
Zerlasiran shows beneficial outcomes for cardiovascular disease reveals phase 2 study

Added to Collection on: 2024-03-23 11:37:47

Tags for this article:

Silence Therapeutics
Lipoprotein
Atherosclerosis
RNA interference
Cardiovascular disease

Click the tags to see associated articles and topics

View Article Details
AstraZeneca, CSPC deal shows Lp(a) space remains hot, says BMO Capital - TipRanks.com

Added to Collection on: 2024-10-07 15:34:53

Tags for this article:

Alnylam Pharmaceuticals
Therapeutic gene modulation
Silence Therapeutics
CRSP
CRISPR Therapeutics
Roche
Bristol-Myers Squibb
CSPC Pharmaceutical
AstraZeneca
BMO CAPITAL

Click the tags to see associated articles and topics

View Article Details
Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR | tctmd.com

Added to Collection on: 2024-11-18 22:08:13

Tags for this article:

Apolipoproteins
Cardiology
Lipoprotein
RNA
PCSK9
Apolipoprotein B
Silence Therapeutics
Low-density lipoprotein
Erin D. Michos
Atherosclerosis
Small interfering RNA
Steven Nissen
Erin Michos
Stephen Nicholls

Click the tags to see associated articles and topics

View Article Details
Lepodisiran's Large, Durable Lp(a) Reductions in Phase 2 Trial Boost Anticipation of ... - Consult QD

Added to Collection on: 2025-04-01 13:38:39

Tags for this article:

RNA
Molecular biology
Hypolipidemic agents
Lepodisiran
Lipoprotein
Small interfering RNA
Silence Therapeutics
Olpasiran
Steven Nissen

Click the tags to see associated articles and topics

View Article Details